LESSONS LEARNED FROM COVID-19

After several months of crisis, we can discern some of the key lessons learned from COVID-19 for the future of pharmaceutical policy in Europe.

More details

Watch Webinar





Become a member

What's new

COVID-19 a lightning rod for major overhaul of EU pharmaceutical policy

Read more

Did you know?

A generic medicine provides the same quality, safety and efficacy as the original brand name product.

Publications

Factsheets
View
Infographics
View
Reports
View
Policy
View
Code of conduct
View

View all

VIDEO GALLERY

Annual Medicines for Europe and IGBA Conference 2019
4 April 2019
17th Biosimilar Medicines Conference
16 November 2018
15th Legal Affairs Conference
14 December 2018

View all

PHOTO GALLERY

19th Regulatory and Scientific Affairs Conference
19th Regulatory and Scientific Affairs Conference
30-31 January 2020
13th Pharmacovigilance Conference
13th Pharmacovigilance Conference
29 January 2020
18th Regulatory and Scientific Affairs Conference
17th Biosimilar Medicines Conference
28-29 March 2019

View all